Riskpilot← Back to searchSign inGet full accessANICURA AS
ASActiveOrg 998675375Hoffsveien 70C, 0377 OsloVeterinary activities · NACE 7500Est. 20120 employees
Revenue 2022
NOK 658K
-68% vs 2021
EBITDA margin
78.4%
-68% vs 2021
Equity ratio
100.0%
Financial strength
Net profit 2022
NOK 640K
+117% vs 2021
| Revenue | NOK 658K | -68% |
| EBITDA | NOK 516K | -68% |
| Net profit | NOK 640K | +117% |
| Total assets | NOK 694,3M | +301% |
| Equity | NOK 694,3M | +1963% |
| Employees | 0 | — |
Legal name
ANICURA AS
Org number
998675375
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
4. august 2012
Share capital
NOK 45 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Direkte eller indirekte, å eie og forvalte aksjer og verdipapirer, samt å drive annen virksomhet som står i forbindelse med det.
Address
Hoffsveien 70C, 0377 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 0 | 194 | 1 219 | 2 049 | 658 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −123 | 51 | 901 | 1 633 | 516 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −123 | 51 | 901 | 1 633 | 516 |
| Net financials | 101 544 | −6 469 | −939 | −6 518 | 304 |
| Profit before tax | 101 421 | −6 418 | −38 | −4 885 | 820 |
| Tax | −0 | 8 | −8 | −1 075 | 180 |
| Net profit | 101 421 | −6 426 | −30 | −3 810 | 640 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 263 639 | 162 474 | 169 555 | 173 097 | 694 315 |
| Equity | 43 916 | 37 490 | 37 460 | 33 650 | 694 264 |
| Long-term debt | 117 702 | 123 636 | 128 989 | 128 989 | 0 |
| Short-term debt | 102 021 | 1 348 | 3 106 | 10 459 | 51 |
| Total debt | 219 723 | 124 984 | 132 095 | 139 447 | 51 |
EBITDA margin
78.4%
This company
15.8%
Market median
+396% vs market
20182022
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20182022
Return on equity
0.1%
This company
18.4%
Market median
-99% vs market
20182022
Net profit margin
97.2%
This company
8.1%
Market median
+1100% vs market
20182022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182022
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LN Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
JD Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Djursjukhusgruppen Sverige Ab | Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ANICURA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørn Dreyer | Chief Executive Officer | 0 companies |
| Lill Nyseter Kortgaard | Chief Executive Officer | 0 companies |
| Line Kristiansen Flamme | Board of Directors | 0 companies |
| Jakko Vinken | Board of Directors | 0 companies |